dansylsarcosine has been researched along with sarcosine in 37 studies
Studies (dansylsarcosine) | Trials (dansylsarcosine) | Recent Studies (post-2010) (dansylsarcosine) | Studies (sarcosine) | Trials (sarcosine) | Recent Studies (post-2010) (sarcosine) |
---|---|---|---|---|---|
40 | 1 | 5 | 1,550 | 69 | 520 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (16.22) | 18.7374 |
1990's | 22 (59.46) | 18.2507 |
2000's | 5 (13.51) | 29.6817 |
2010's | 4 (10.81) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dengler, HJ; Dengler, TJ; Robertz-Vaupel, GM | 1 |
Preissner, A; Rietbrock, N; Wörner, W | 1 |
Bowmer, CJ; Panjehshahin, MR; Yates, MS | 3 |
Kratzer, W; Pfleiderer, S; Rietbrock, N; Wörner, W | 1 |
Bowmer, CJ; Mackay, D; Panjehshahin, MR | 1 |
Cittanova, N; Desfosses, B; Urbach, W; Waks, M | 1 |
Maehira, F | 1 |
Brater, DC; Kirchner, KA; Voelker, JR | 1 |
Menke, G; Pfister, P; Rietbrock, I; Rietbrock, N; Sauerwein, S; Woodcock, BG | 1 |
Hanano, M; Kurita, M; Sugimoto, T; Sugiyama, Y; Takikawa, H; Yoshida, H | 1 |
Birkett, DJ; Wanwimolruk, S | 1 |
Birkett, DJ; Brooks, PM; Wanwimolruk, S | 1 |
Brunner, F; Tillement, JP; Zini, R | 1 |
Maruyama, T; Okada, T; Otagiri, M; Rahman, MH; Yamasaki, K | 1 |
Nerli, B; Pico, G | 1 |
Drelon, E; Lapicque, F; Muller, N; Netter, P | 1 |
Keita, Y; Kratzer, W; Rietbrock, N; Wörner, W | 1 |
Fuhr, U; Keita, Y; Veile, G; Woodcock, BG; Wörner, W | 1 |
Bowmer, CJ; Grigg, RE; McCormack, A; Munsey, T; Symonds, HW | 1 |
Otagiri, M; Sakai, T; Takadate, A | 1 |
Kunugi, S; Nishizawa, H; Tanaka, N | 1 |
Enomoto, S; Hoshiyama, K; Izumi, T; Sasahara, K; Sugiyama, Y | 1 |
Bowmer, CJ; Rajaian, H; Symonds, HW | 1 |
Buckland, AG; Thumser, AE; Wilton, DC | 1 |
East, MJ; Fish, BC; Gore, MG; Lee, AG; Turner, A; Twine, SM | 1 |
Gu, C; Lai, J; Nikolic, D; van Breemen, RB; Xu, X | 1 |
Caravan, P; Greenfield, MT; Li, X; Sherry, AD | 1 |
Liang, Y; Ni, K; Tu, S; Wang, Y; Yu, JS; Zhong, W | 1 |
Flarakos, J; Morand, KL; Vouros, P | 1 |
Kosa, T; Maruyama, T; Nishi, K; Otagiri, M; Sakai, N; Suenaga, A; Watanabe, H; Yonemura, N | 1 |
Emmrich, J; Heemann, U; Klammt, S; Loock, J; Mitzner, SR; Reisinger, EC; Schmidt, R; Stange, J | 1 |
Chung, CW; Curry, S; Ghuman, J; Ryan, AJ; Zunszain, PA | 1 |
Cohen, MP; Hud, E; Lautenslager, GT; Shearman, CW | 1 |
Anraku, M; Chuang, VT; Kawai, K; Komatsu, T; Maruyama, T; Otagiri, M; Seo, H; Taguchi, K; Tanaka, R; Urata, Y; Yamasaki, K | 1 |
Ascenzi, P; Fanali, G; Fasano, M; Leboffe, L; Polticelli, F; Tortosa, V; Trezza, V | 1 |
1 trial(s) available for dansylsarcosine and sarcosine
Article | Year |
---|---|
Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis.
Topics: Adult; Albumins; Benzodiazepines; Bile Acids and Salts; Bilirubin; Binding Sites; Dansyl Compounds; Dialysis; Female; Fibrosis; Humans; Liver Failure; Male; Middle Aged; Sarcosine; Treatment Outcome | 2008 |
36 other study(ies) available for dansylsarcosine and sarcosine
Article | Year |
---|---|
Albumin binding in uraemia: quantitative assessment of inhibition by endogenous ligands and carbamylation of albumin.
Topics: Amino Acid Sequence; Binding, Competitive; Carbamates; Dansyl Compounds; Fluorescent Dyes; Glycine; Humans; Kinetics; Ligands; Molecular Sequence Data; Protein Binding; Sarcosine; Serum Albumin; Spectrometry, Fluorescence; Uremia | 1992 |
Drug-protein binding kinetics in patients with type I diabetes.
Topics: Adult; Dansyl Compounds; Diabetes Mellitus, Type 1; Humans; Middle Aged; Protein Binding; Sarcosine; Serum Albumin | 1992 |
A comparison of drug binding sites on mammalian albumins.
Topics: Albumins; Animals; Binding Sites; Binding, Competitive; Cattle; Dansyl Compounds; Diazepam; Dogs; Fatty Acids, Nonesterified; Fluorescence; Horses; Humans; Hydrogen-Ion Concentration; Kinetics; Nitrophenols; Phenylbutazone; Rats; Sarcosine; Sheep; Warfarin | 1992 |
[Non-enzymatic glycation of human serum albumin: influence on thebinding kinetics of the benzodiazepine binding sites].
Topics: Benzodiazepines; Binding Sites; Chromatography, Affinity; Dansyl Compounds; Humans; Kinetics; Sarcosine; Serum Albumin | 1990 |
Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin.
Topics: Binding Sites; Binding, Competitive; Dansyl Compounds; Diazepam; Fatty Acids; Fatty Acids, Unsaturated; Humans; In Vitro Techniques; Phenylbutazone; Protein Binding; Sarcosine; Serum Albumin; Structure-Activity Relationship; Valproic Acid; Warfarin | 1991 |
Analysis of the binding of fluorescent ligands to soluble proteins. Use of simultaneous non-linear least squares regression to obtain estimates of binding parameters.
Topics: Albumins; Anilino Naphthalenesulfonates; Dansyl Compounds; Fluorescence; Fluorescent Dyes; Humans; Kinetics; Ligands; Linear Models; Models, Biological; Proteins; Regression Analysis; Sarcosine; Software; Warfarin | 1991 |
Ligand binding at membrane mimetic interfaces. Human serum albumin in reverse micelles.
Topics: Circular Dichroism; Dansyl Compounds; Hemin; Humans; Ligands; Micelles; Oxidation-Reduction; Oxyphenbutazone; Sarcosine; Serum Albumin; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Tryptophan | 1991 |
High prostaglandin-E1 binding to serum protein in allergic subjects.
Topics: Alprostadil; Binding Sites; Binding, Competitive; Dansyl Compounds; Dialysis; Fluorescence; Humans; Hypersensitivity; Protein Binding; Salicylates; Salicylic Acid; Sarcosine; Serum Albumin | 1991 |
Binding inhibitors restore furosemide potency in tubule fluid containing albumin.
Topics: Albumins; Animals; Binding Sites; Binding, Competitive; Body Fluids; Dansyl Compounds; Drug Tolerance; Furosemide; Kidney Tubules, Distal; Male; Nephrotic Syndrome; Perfusion; Protein Binding; Rats; Rats, Inbred Strains; Sarcosine; Sulfisoxazole; Warfarin | 1991 |
Age-dependence and free fatty acid modulation of binding kinetics at the benzodiazepine binding site of serum albumin in neonates and adults determined using fast reaction methods.
Topics: Adult; Aged; Aging; Blood Proteins; Dansyl Compounds; Fatty Acids, Nonesterified; Humans; Infant, Newborn; Kinetics; Middle Aged; Protein Binding; Receptors, GABA-A; Sarcosine; Serum Albumin | 1987 |
A novel binding site for bile acids on human serum albumin.
Topics: Bile Acids and Salts; Bilirubin; Binding Sites; Coumarins; Dansyl Compounds; Fatty Acids, Unsaturated; Fluorescent Dyes; Glucuronates; Humans; Kinetics; Oleic Acid; Oleic Acids; Sarcosine; Serum Albumin | 1987 |
A pitfall in the use of double-reciprocal plots to estimate the intrinsic molar fluorescence of ligands bound to albumin.
Topics: Albumins; Anilino Naphthalenesulfonates; Dansyl Compounds; Fluorescence; Protein Binding; Sarcosine; Warfarin | 1989 |
The effects of N-B transition of human serum albumin on the specific drug-binding sites.
Topics: Binding Sites; Calcium; Chlorides; Dansyl Compounds; Humans; Hydrogen-Ion Concentration; Oleic Acid; Oleic Acids; Protein Binding; Protein Conformation; Sarcosine; Serum Albumin; Warfarin | 1982 |
Structural requirements for drug binding to site II on human serum albumin.
Topics: Amines; Anti-Inflammatory Agents; Binding Sites; Binding, Competitive; Dansyl Compounds; Diazepam; Fatty Acids; Humans; In Vitro Techniques; Molecular Weight; Pharmaceutical Preparations; Propionates; Protein Binding; Sarcosine; Serum Albumin; Solubility; Structure-Activity Relationship | 1983 |
Plasma protein binding of metbufen, a new non-steroid anti-inflammatory drug, in humans.
Topics: Anti-Inflammatory Agents; Binding Sites; Blood Proteins; Dansyl Compounds; Humans; Hyperbilirubinemia; In Vitro Techniques; Phenylbutyrates; Propionates; Protein Binding; Sarcosine; Serum Albumin | 1984 |
Study of interaction of carprofen and its enantiomers with human serum albumin--I. Mechanism of binding studied by dialysis and spectroscopic methods.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Carbazoles; Dansyl Compounds; Fluorescence; Humans; Hydrogen-Ion Concentration; Protein Binding; Sarcosine; Serum Albumin; Spectrophotometry, Ultraviolet; Stereoisomerism; Structure-Activity Relationship; Temperature | 1993 |
Identification of the cephalosporin human serum albumin binding sites.
Topics: Bilirubin; Binding Sites; Cephalosporins; Dansyl Compounds; Humans; In Vitro Techniques; Sarcosine; Serum Albumin; Spectrometry, Fluorescence; Tretinoin | 1993 |
Binding sites of fluorescent probes on human serum albumin.
Topics: Binding Sites; Binding, Competitive; Circular Dichroism; Dansyl Compounds; Digitoxin; Fluorescent Dyes; Glycine; Humans; Phenylbutazone; Sarcosine; Serum Albumin; Spectrometry, Fluorescence | 1994 |
Effect of free fatty acids on the binding kinetics at the benzodiazepine binding site of glycated human serum albumin.
Topics: Benzodiazepines; Dansyl Compounds; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Glycated Serum Albumin; Glycation End Products, Advanced; Glycosylation; Humans; Kinetics; Linoleic Acid; Linoleic Acids; Oleic Acid; Oleic Acids; Protein Binding; Sarcosine; Serum Albumin; Stearic Acids | 1993 |
Influence of non-steroidal anti-inflammatory drugs on the binding kinetics of dansylsarcosine to human serum albumin. Stereoselectivity, steric and inductive effects.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dansyl Compounds; Humans; Protein Binding; Sarcosine; Serum Albumin; Stereoisomerism; Structure-Activity Relationship | 1996 |
Binding of sulphamethazine to pig plasma proteins and albumin.
Topics: Analysis of Variance; Animals; Anti-Infective Agents; Binding Sites; Blood Proteins; Dansyl Compounds; Fluorescent Dyes; Hydrogen-Ion Concentration; Male; Protein Binding; Sarcosine; Serum Albumin; Sulfamethazine; Swine; Thermodynamics; Warfarin | 1996 |
Characterization of binding site of uremic toxins on human serum albumin.
Topics: Binding Sites; Dansyl Compounds; Furans; Hippurates; Humans; Indoleacetic Acids; Indoles; Propionates; Sarcosine; Serum Albumin; Uremia; Warfarin | 1995 |
Structure of pressure-induced denatured state of human serum albumin: a comparison with the intermediate in urea-induced denaturation.
Topics: Bilirubin; Circular Dichroism; Dansyl Compounds; Fluorescent Dyes; Humans; Pressure; Protein Conformation; Protein Denaturation; Sarcosine; Serum Albumin; Spectrometry, Fluorescence; Urea; Warfarin | 1997 |
Determination of protein binding of troglitazone stereoisomers by fluorometric titration.
Topics: Animals; Binding Sites; Binding, Competitive; Chromans; Dansyl Compounds; Fluorescent Dyes; Humans; Hypoglycemic Agents; Male; Mice; Protein Binding; Rats; Sarcosine; Serum Albumin; Species Specificity; Spectrometry, Fluorescence; Stereoisomerism; Thiazoles; Thiazolidinediones; Titrimetry; Troglitazone | 1997 |
Drug binding sites on chicken albumin: a comparison to human albumin.
Topics: Albumins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Apazone; Binding Sites; Chickens; Dansyl Compounds; Humans; Hydrogen-Ion Concentration; Hydrolysis; Ligands; Nitrophenols; Sarcosine; Species Specificity; Warfarin | 1997 |
Monoacylglycerol binding to human serum albumin: evidence that monooleoylglycerol binds at the dansylsarcosine site.
Topics: Binding Sites; Dansyl Compounds; Glycerides; Humans; In Vitro Techniques; Kinetics; Oleic Acid; Sarcosine; Serum Albumin; Spectrometry, Fluorescence | 1998 |
Characterisation of domain fragments of recombinant human albumin.
Topics: Binding Sites; Binding, Competitive; Dansyl Compounds; Humans; Kinetics; Peptide Fragments; Phenylbutazone; Recombinant Proteins; Sarcosine; Serum Albumin; Spectrometry, Fluorescence | 1998 |
Assays of ligand-human serum albumin binding using pulsed ultrafiltration and liquid chromatography-mass spectrometry.
Topics: Chromatography, Liquid; Dansyl Compounds; Humans; Ligands; Mass Spectrometry; Sarcosine; Serum Albumin; Ultrafiltration; Warfarin | 1999 |
The Gd(3+) complex of a fatty acid analogue of DOTP binds to multiple albumin sites with variable water relaxivities.
Topics: Algorithms; Binding Sites; Chemical Phenomena; Chemistry, Physical; Dansyl Compounds; Fatty Acids; Fluorescence; Gadolinium; Humans; Ligands; Models, Molecular; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Organophosphonates; Organophosphorus Compounds; Proteins; Sarcosine; Serum Albumin; Water | 2001 |
The interaction of human serum albumin with a novel antidiabetic agent--SU-118.
Topics: Binding Sites; Coumarins; Dansyl Compounds; Desulfurococcaceae; Fluorescent Dyes; Humans; Hypoglycemic Agents; Microscopy, Fluorescence; Protein Binding; Sarcosine; Serum Albumin; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Sulfonylurea Compounds; Thermodynamics; Tryptophan | 2004 |
High-throughput solution-based medicinal library screening against human serum albumin.
Topics: Acecainide; beta-Lactams; Chromatography, Gel; Chromatography, Liquid; Combinatorial Chemistry Techniques; Dansyl Compounds; Humans; Imipramine; Indomethacin; Pharmaceutical Preparations; Protein Binding; Quinidine; Reproducibility of Results; Sarcosine; Serum Albumin; Tandem Mass Spectrometry; Tryptophan; Warfarin | 2005 |
Structural and ligand-binding properties of serum albumin species interacting with a biomembrane interface.
Topics: Animals; Circular Dichroism; Dansyl Compounds; Dogs; Humans; Ligands; Membranes; Micelles; Oxyphenbutazone; Protein Binding; Rabbits; Rats; Sarcosine; Serum Albumin; Species Specificity; Spectrometry, Fluorescence | 2007 |
Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin.
Topics: Arginine; Asparagine; Dansyl Compounds; Glutamates; Humans; Phenylalanine; Protein Binding; Sarcosine; Serum Albumin | 2011 |
Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin.
Topics: Dansyl Compounds; Fatty Acids, Unsaturated; Fluorescence; Glycosylation; Humans; Linoleic Acid; Oleic Acid; Palmitic Acid; Sarcosine; Serum Albumin; Warfarin | 2011 |
Cross-linked human serum albumin dimer has the potential for use as a plasma-retaining agent for the fatty acid-conjugated antidiabetic drugs.
Topics: Animals; Binding Sites; Dansyl Compounds; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dimerization; Drug Carriers; Fatty Acids; Fluorescent Dyes; Half-Life; Humans; Hypoglycemic Agents; Male; Maleimides; Permeability; Plasma; Protein Binding; Rats; Rats, Sprague-Dawley; Sarcosine; Serum Albumin; Warfarin | 2015 |
Cantharidin inhibits competitively heme-Fe(III) binding to the FA1 site of human serum albumin.
Topics: Binding, Competitive; Cantharidin; Dansyl Compounds; Fatty Acids; Heme; Humans; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Sarcosine; Serum Albumin, Human; Thermodynamics | 2017 |